Dr. Joseph M Malters , MD
Dermatology • Rolla, MO
10101 Stoltz Dr
Rolla, MO 654017714
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
NPI assigned on October 4, 2006; this date does not establish years in practice.
-
Published CMS data list 1,822 Original Medicare Part B services in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Published rows only; this is not a quality measure.
-
Published Part B service records, 2024:
- 17003 — Destruction of precancer skin growth, 2-14 growths: 644 service units.
- 99213 — Established patient outpatient office visit: 414 service units.
- 17000 — Destruction of precancer skin growth, 1 growth: 260 service units.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Units differ by code; these are not visits or a measure of quality.
CPT® only copyright 2023 American Medical Association. All rights reserved. Service names are shortened from CPT Consumer Friendly Descriptors (CMS data, 2024). CPT notice
See all 16 records in the table · Guide: How to read Medicare Part B data
-
Published CMS data list 594 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Doxycycline Hyclate — 77 prescription fills, including refills.
- Mometasone Furoate — 66 prescription fills, including refills.
- Triamcinolone Acetonide — 54 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 19 records in the table · Guide: How to read Medicare Part D prescriber data
-
Fewer Medicare Part B services than 60% of clinicians listed under Dermatology in Missouri (2024, 172 clinicians with data). Median for this group: 2,847. Middle half: 1,311 to 5,295.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part B services went from 4,718 in 2020 to 1,822 in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2020–2024.
Practice Location & Contact Primary Location
10101 Stoltz Dr
Rolla, MO 654017714
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
What Public CMS Data Show
Dermatology: NPPES taxonomy is a reported classification, not proof of board certification.
Medicare patients
692 people with Original Medicare in 2024
It gives a sense of how many people with Medicare this clinician treated that year.
Source: CMS, Medicare Physician & Other Practitioners – by Provider, 2024.
Medicare-allowed amount
About $104,558 in 2024
The total amount Medicare approved for these services in 2024. It includes what Medicare paid and what patients or their other insurance owed, such as the deductible and coinsurance.
It shows the total cost of this clinician's Original Medicare services under Medicare's fee rules.
What this does not show: Medicare-allowed amount
This is not the clinician's income. Part of it can go to a clinic or group practice, staff, equipment or drugs. It is not the price you will pay.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
Paid by Medicare
About $69,829 in 2024
The part of the Medicare-allowed amount that Medicare itself paid in 2024, after patients' deductibles and coinsurance.
The gap between the allowed amount and this number is roughly what patients and their other insurance paid.
What this does not show: Paid by Medicare
This is not the clinician's income and not a measure of quality.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
30-day fills
661 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$690,877 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024.
Open Payments general payments, program year 2024
All general payments: $827.21 across 42 records.
By nature of payment
- Food and Beverage: $723.77 across 40 records.
- Education: $103.44 across 2 records.
Reporting-company totals (3 largest of 13)
- ABBVIE INC.: $227.89 across 13 records.
- Janssen Pharmaceuticals, Inc: $158.37 across 6 records.
- LEO Pharma Inc.: $117.22 across 5 records.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2024 (published June 30, 2026).
NPI first issued
2006
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Medicare assignment not listed
CMS data do not show whether this clinician accepts Medicare assignment. This does not mean they do not accept Medicare. Ask the office.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians; Medicare.gov, “Does your provider accept Medicare as full payment?”
No telehealth indicator
CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians.
Enrolled in Medicare (PECOS)
Dr. Malters has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.
It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Can order Medicare-covered services
CMS lists Dr. Malters as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.
Medicare pays for these items and services only when they are ordered by an eligible clinician.
What this does not show: Can order Medicare-covered services
It does not mean the clinician offers these services directly.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Compared with the same specialty in Rolla and Missouri
Billing and prescribing volume is not a quality rating.
Medicare Part B services
Fewer Medicare Part B services than 60% of clinicians listed under Dermatology in Missouri (2024, 172 clinicians with data). Median for this group: 2,847. Middle half: 1,311 to 5,295.
Too few clinicians listed under Dermatology in Rolla have Medicare Part B data for 2024 to compare.
Medicare-allowed amount
A lower Medicare-allowed amount than 70% of clinicians listed under Dermatology in Missouri (2024, 172 clinicians with data). Median for this group: $179,437. Middle half: $97,811 to $310,038.
Too few clinicians listed under Dermatology in Rolla have Medicare Part B data for 2024 to compare.
Paid by Medicare
A lower Medicare payment amount than 70% of clinicians listed under Dermatology in Missouri (2024, 172 clinicians with data). Median for this group: $123,807. Middle half: $66,619 to $217,529.
Too few clinicians listed under Dermatology in Rolla have Medicare Part B data for 2024 to compare.
Medicare Part D prescriptions
Close to the middle for clinicians listed under Dermatology in Missouri (2024, 192 clinicians with data). Median for this group: 757. Middle half: 294 to 1,190.
Too few clinicians listed under Dermatology in Rolla have Medicare Part D data for 2024 to compare.
Part D drug cost
A higher Part D drug cost than 85% of clinicians listed under Dermatology in Missouri (2024, 192 clinicians with data). Median for this group: $117,786. Middle half: $11,892 to $467,958.
Too few clinicians listed under Dermatology in Rolla have Medicare Part D data for 2024 to compare.
2 active clinicians are listed under Dermatology with a practice address in Rolla, MO (279 in Missouri).
Addresses are self-reported to NPPES and may be out of date.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part B services
Medicare Part B services decreased 61% from 4,718 in 2020 to 1,822 in 2024.
- 2020: 4,718
- 2021: 4,404
- 2022: 4,360
- 2023: 4,460
- 2024: 1,822
-
Medicare-allowed amount
Medicare-allowed amount decreased 62% from $271,686 in 2020 to $104,558 in 2024.
- 2020: $271,686
- 2021: $296,305
- 2022: $286,240
- 2023: $277,923
- 2024: $104,558
-
Paid by Medicare
Paid by Medicare decreased 63% from $189,965 in 2020 to $69,829 in 2024.
- 2020: $189,965
- 2021: $210,600
- 2022: $200,096
- 2023: $197,607
- 2024: $69,829
-
Medicare Part D prescriptions
Medicare Part D prescriptions decreased 32% from 873 in 2020 to 594 in 2024.
- 2020: 873
- 2021: 970
- 2022: 957
- 2023: 978
- 2024: 594
-
30-day fills
30-day fills decreased 31% from 951 in 2020 to 661 in 2024.
- 2020: 951
- 2021: 1,050
- 2022: 1,069
- 2023: 1,090
- 2024: 661
-
Part D drug cost
Part D drug cost increased 17% from $588,443 in 2020 to $690,877 in 2024.
- 2020: $588,443
- 2021: $485,898
- 2022: $752,485
- 2023: $942,232
- 2024: $690,877
-
Industry payments (Open Payments)
Industry payments (Open Payments) went from $253.42 in 2020 to $827.21 in 2024.
- 2020: $253.42
- 2021: $1,095.21
- 2022: $1,288.32
- 2023: $1,668.21
- 2024: $827.21
Sources: CMS Medicare Physician & Other Practitioners (2024), CMS Medicare Part D Prescribers (2024), CMS Open Payments (2024), CMS Doctors and Clinicians, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo · Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2024 (payments made January 1 – December 31, 2024): 42 records totaling $827.21.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| Janssen Pharmaceuticals, Inc |
Education
In-kind items and services
|
TREMFYA | General | $94.99 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
RINVOQ | General | $29.72 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
SKYRIZI | General | $27.10 |
| Sanofi and Genzyme US Companies |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $26.49 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
RINVOQ | General | $25.79 |
| UCB, Inc. |
Food and Beverage
In-kind items and services
|
Bimzelx | General | $24.82 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
RINVOQ | General | $24.61 |
| LEO Pharma Inc. |
Food and Beverage
In-kind items and services
|
ADBRY | General | $24.04 |
| LEO Pharma Inc. |
Food and Beverage
In-kind items and services
|
ADBRY | General | $24.02 |
| LEO Pharma Inc. |
Food and Beverage
In-kind items and services
|
ADBRY | General | $23.65 |
| LEO Pharma Inc. |
Food and Beverage
In-kind items and services
|
ADBRY | General | $23.14 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
HUMIRA | General | $22.40 |
| Fresenius Kabi USA, LLC |
Food and Beverage
In-kind items and services
|
IDACIO | General | $22.38 |
| LEO Pharma Inc. |
Food and Beverage
In-kind items and services
|
ADBRY | General | $22.37 |
| UCB, Inc. |
Food and Beverage
In-kind items and services
|
Bimzelx | General | $22.26 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
RINVOQ | General | $21.45 |
| Bristol Myers Squibb Company |
Food and Beverage
Cash or cash equivalent
|
Sotyktu | General | $20.00 |
| Regeneron Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $19.47 |
| Pfizer Inc. |
Food and Beverage
In-kind items and services
|
EUCRISA | General | $19.36 |
| Janssen Pharmaceuticals, Inc |
Food and Beverage
In-kind items and services
|
TREMFYA | General | $19.04 |
| Sanofi and Genzyme US Companies |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $18.31 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
RINVOQ | General | $17.65 |
| Bristol Myers Squibb Company |
Food and Beverage
Cash or cash equivalent
|
Sotyktu | General | $17.28 |
| Amgen Inc. |
Food and Beverage
In-kind items and services
|
Otezla | General | $17.05 |
| Eli Lilly and Company |
Food and Beverage
In-kind items and services
|
TALTZ | General | $17.05 |
(top 25 shown)
Source: CMS Open Payments, program year 2024, released June 30, 2026.
Performed Procedures & Service Volume
CPT® is a registered trademark of the American Medical Association. CPT codes, descriptions and other data only are copyright 2016–2023 American Medical Association. All rights reserved. Applicable FARS/HHSARS apply. Descriptions of CPT codes are the AMA's CPT Consumer Friendly Descriptors as published by CMS in the Medicare Physician & Other Practitioners – by Provider and Service data, 2017–2024; they are plain-language summaries, not for clinical coding or documentation. HCPCS Level II codes and descriptions are from CMS. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.
| HCPCS Code | Services | Patients | Submitted Charge | Medicare Allowed |
|---|---|---|---|---|
|
17003
Destruction of precancer skin growth, 2-14 growths
|
644 | 186 | $24.00 | $5.83 |
|
99213
Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
|
414 | 380 | $110.05 | $82.76 |
|
17000
Destruction of precancer skin growth, 1 growth
|
260 | 245 | $110.00 | $52.94 |
|
99212
Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more
|
122 | 117 | $94.21 | $50.84 |
|
11102
Biopsy of related skin growth, first growth
|
86 | 83 | $143.00 | $80.60 |
|
99203
New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more
|
64 | 64 | $176.00 | $101.16 |
|
17281
Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm
|
34 | 28 | $287.00 | $141.38 |
|
11642
Removal of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm
|
33 | 29 | $428.00 | $175.62 |
|
17110
Destruction of skin growth, 1-14 growths
|
29 | 29 | $145.00 | $93.98 |
|
11104
Punch biopsy, first skin growth
|
27 | 24 | $171.00 | $105.96 |
|
17261
Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm
|
27 | 22 | $227.00 | $108.00 |
|
11602
Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm
|
21 | 19 | $388.00 | $158.19 |
|
12052
Intermediate repair of wound of face, ears, eyelids, nose, lips, or mouth, 2.6-5.0 cm
|
18 | 17 | $484.00 | $265.69 |
|
11641
Removal of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm
|
17 | 16 | $374.00 | $192.91 |
|
99202
New patient office or other outpatient visit with straightforward medical decision making, if using time, 15 minutes or more
|
14 | 14 | $132.00 | $65.65 |
|
17262
Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm
|
12 | 11 | $276.00 | $146.70 |
Source: CMS Part B by Provider and Service, 2024; services under 11 beneficiaries omitted by CMS. Privacy limits
Submitted charges are billed amounts, not a price quote for your visit.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Doxycycline Hyclate | Doxycycline Hyclate | 77 | 1,972 | $1,032.45 | 36 |
| Mometasone Furoate | Mometasone Furoate | 66 | 1,722 | $1,325.64 | 38 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 54 | 1,715 | $614.48 | 29 |
| Hydrocortisone | Hydrocortisone | 48 | 1,073 | $190.60 | 31 |
| Fluorouracil | Fluorouracil | 47 | 1,307 | $3,522.12 | 38 |
| Fluocinonide | Fluocinonide | 44 | 1,681 | $1,455.09 | 26 |
| Dupixent Pen | Dupilumab | 41 | 1,148 | $165,087.85 | — |
| Imiquimod | Imiquimod | 32 | 588 | $510.81 | 26 |
| Cosentyx Sensoready (2 Pens) | Secukinumab | 27 | 756 | $195,764.37 | — |
| Rinvoq | Upadacitinib | 24 | 720 | $172,129.01 | — |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 20 | 660 | $124.59 | — |
| Clobetasol Propionate | Clobetasol Propionate | 17 | 653 | $577.73 | 13 |
| Humira(Cf) Pen | Adalimumab | 17 | 476 | $146,468.63 | — |
| Mupirocin | Mupirocin | 16 | 450 | $137.83 | 12 |
| Spironolactone | Spironolactone | 15 | 810 | $111.19 | — |
| Fluconazole | Fluconazole | 13 | 580 | $99.99 | — |
| Ketoconazole | Ketoconazole | 13 | 405 | $197.84 | — |
| Cimetidine | Cimetidine | 12 | 360 | $129.62 | — |
| Metronidazole | Metronidazole | 11 | 320 | $1,397.46 | — |
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
Self-certified to NPPES: 2020-10-01NUCC Taxonomy Code: 207N00000X
A dermatologist is trained to diagnose and treat pediatric and adult patients with benign and malignant disorders of the skin, mouth, external genitalia, hair and nails, as well as a number of sexually transmitted diseases. The dermatologist has had additional training and experience in the diagnosis and treatment of skin cancers, melanomas, moles and other tumors of the skin, the management of contact dermatitis and other allergic and nonallergic skin disorders, and in the recognition of the skin manifestations of systemic (including internal malignancy) and infectious diseases. Dermatologists have special training in dermatopathology and in the surgical techniques used in dermatology. They also have expertise in the management of cosmetic disorders of the skin such as hair loss and scars and the skin changes associated with aging.
NUCC Taxonomy Code: 207ND0101X
The highly-trained surgeons that perform Mohs Micrographic Surgery are specialists both in dermatology and pathology. With their extensive knowledge of the skin and unique pathological skills, they are able to remove only diseased tissue, preserving healthy tissue and minimizing the cosmetic impact of the surgery. Mohs surgeons who belong to the American College of Mohs Surgery (ACMS) have completed a minimum of one year of fellowship training at one of the ACMS-approved training centers in the U.S.
Additional State Medicaid & Healthcare Payer Identifiers
Medicare (PECOS) Enrollment & Ordering Eligibility
Source: CMS PECOSPRACTITIONER - DERMATOLOGY
I20101026000256
MO
2466645254
Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.
Clinicians Sharing This Practice Address or Phone
Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.
Dermatology
Doctor of Medicine (M.D.)
Career & Practice History Timeline
Changes recorded in monthly NPPES data files: addresses, names, credentials, specialties and NPI status
Dermatology (license number reported to NPPES: MO 2001027199)
NPI status registered as active in NPPES database
Registered at 10101 STOLTZ DR, ROLLA, MO 654017714 (Tel: 5733640122)
Registered at 10101 STOLTZ DR, ROLLA, MO 654017714 (Tel: 5733640122)
Recorded as JOSEPH MALTERS, M.D.
Dermatology (license number reported to NPPES: MO MO2001027199)
First registered as active Individual Practitioner in NPPES Database.
NPI Administrative Meta
Mailing Address
10101 Stoltz Dr
Rolla, MO 654017714
Phone: 5733640122